These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 22403241

  • 21. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
    MacDonnell SM, Weisser-Thomas J, Kubo H, Hanscome M, Liu Q, Jaleel N, Berretta R, Chen X, Brown JH, Sabri AK, Molkentin JD, Houser SR.
    Circ Res; 2009 Aug 14; 105(4):316-25. PubMed ID: 19608982
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
    Lunde IG, Aronsen JM, Melleby AO, Strand ME, Skogestad J, Bendiksen BA, Ahmed MS, Sjaastad I, Attramadal H, Carlson CR, Christensen G.
    Mol Biol Rep; 2022 Dec 14; 49(12):11795-11809. PubMed ID: 36205855
    [Abstract] [Full Text] [Related]

  • 24. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
    Liu W, Zi M, Jin J, Prehar S, Oceandy D, Kimura TE, Lei M, Neyses L, Weston AH, Cartwright EJ, Wang X.
    Circ Res; 2009 Apr 10; 104(7):905-14. PubMed ID: 19265040
    [Abstract] [Full Text] [Related]

  • 25. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation.
    Kirschmer N, Bandleon S, von Ehrlich-Treuenstätt V, Hartmann S, Schaaf A, Lamprecht AK, Miranda-Laferte E, Langsenlehner T, Ritter O, Eder P.
    PLoS One; 2016 Apr 10; 11(12):e0168446. PubMed ID: 27992507
    [Abstract] [Full Text] [Related]

  • 26. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
    Echtermeyer F, Harendza T, Hubrich S, Lorenz A, Herzog C, Mueller M, Schmitz M, Grund A, Larmann J, Stypmann J, Schieffer B, Lichtinghagen R, Hilfiker-Kleiner D, Wollert KC, Heineke J, Theilmeier G.
    Cardiovasc Res; 2011 Oct 01; 92(1):123-31. PubMed ID: 21632883
    [Abstract] [Full Text] [Related]

  • 27. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
    Liu W, Zi M, Tsui H, Chowdhury SK, Zeef L, Meng QJ, Travis M, Prehar S, Berry A, Hanley NA, Neyses L, Xiao RP, Oceandy D, Ke Y, Solaro RJ, Cartwright EJ, Lei M, Wang X.
    Circ Heart Fail; 2013 Jul 01; 6(4):833-44. PubMed ID: 23753531
    [Abstract] [Full Text] [Related]

  • 28. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.
    Gao H, Wang F, Wang W, Makarewich CA, Zhang H, Kubo H, Berretta RM, Barr LA, Molkentin JD, Houser SR.
    J Mol Cell Cardiol; 2012 Nov 01; 53(5):657-67. PubMed ID: 22921230
    [Abstract] [Full Text] [Related]

  • 29. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
    Kreusser MM, Lehmann LH, Keranov S, Hoting MO, Oehl U, Kohlhaas M, Reil JC, Neumann K, Schneider MD, Hill JA, Dobrev D, Maack C, Maier LS, Gröne HJ, Katus HA, Olson EN, Backs J.
    Circulation; 2014 Oct 07; 130(15):1262-73. PubMed ID: 25124496
    [Abstract] [Full Text] [Related]

  • 30. Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.
    Hatchi EM, Poalas K, Cordeiro N, N'Debi M, Gavard J, Bidère N.
    Int J Biochem Cell Biol; 2014 Sep 07; 54():217-22. PubMed ID: 25088585
    [Abstract] [Full Text] [Related]

  • 31. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L, van Keulen JK, Hoefer IE, Meijs MF, van Middelaar B, den Ouden K, van Echteld CJ, Pasterkamp G, de Kleijn DP.
    Circ Res; 2009 Mar 13; 104(5):699-706. PubMed ID: 19168865
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B, Bueno OF, Dai YS, Wilkins BJ, Molkentin JD.
    Mol Cell Biol; 2005 Feb 13; 25(3):865-78. PubMed ID: 15657416
    [Abstract] [Full Text] [Related]

  • 34. Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice.
    Nakagawa T, Furukawa Y, Hayashi T, Nomura A, Yokoe S, Moriwaki K, Kato R, Ijiri Y, Yamaguchi T, Izumi Y, Yoshiyama M, Asahi M.
    Hypertens Res; 2019 Dec 13; 42(12):1858-1871. PubMed ID: 31409917
    [Abstract] [Full Text] [Related]

  • 35. Annexin A7 deficiency potentiates cardiac NFAT activity promoting hypertrophic signaling.
    Voelkl J, Alesutan I, Pakladok T, Viereck R, Feger M, Mia S, Schönberger T, Noegel AA, Gawaz M, Lang F.
    Biochem Biophys Res Commun; 2014 Feb 28; 445(1):244-9. PubMed ID: 24508799
    [Abstract] [Full Text] [Related]

  • 36. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M, Gan XT, Huang CX, Rajapurohitam V, Martínez-Abundis E, Lui EM, Karmazyn M.
    Circ Heart Fail; 2012 Jul 01; 5(4):504-14. PubMed ID: 22576957
    [Abstract] [Full Text] [Related]

  • 37. Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.
    Slone S, Anthony SR, Wu X, Benoit JB, Aube J, Xu L, Tranter M.
    Cell Signal; 2016 Nov 01; 28(11):1735-41. PubMed ID: 27521603
    [Abstract] [Full Text] [Related]

  • 38. ZNF307 (Zinc Finger Protein 307) Acts as a Negative Regulator of Pressure Overload-Induced Cardiac Hypertrophy.
    Yu CJ, Liang C, Li YX, Hu QQ, Zheng WW, Niu N, Yang X, Wang ZR, Yu XD, Zhang BL, Song BL, Zhang ZR.
    Hypertension; 2017 Apr 01; 69(4):615-624. PubMed ID: 28223477
    [Abstract] [Full Text] [Related]

  • 39. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
    Zhang Y, Zhang XF, Gao L, Liu Y, Jiang DS, Chen K, Yang Q, Fan GC, Zhang XD, Huang C.
    Biochim Biophys Acta; 2014 Feb 01; 1842(2):232-44. PubMed ID: 24275554
    [Abstract] [Full Text] [Related]

  • 40. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A, Szaroszyk M, Döppner JK, Malek Mohammadi M, Kattih B, Korf-Klingebiel M, Gigina A, Scherr M, Kensah G, Jara-Avaca M, Gruh I, Martin U, Wollert KC, Gohla A, Katus HA, Müller OJ, Bauersachs J, Heineke J.
    Cardiovasc Res; 2019 Jan 01; 115(1):71-82. PubMed ID: 29931050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.